Lanean...
Population pharmacokinetics–pharmacodynamics of sunitinib in pediatric patients with solid tumors
PURPOSE: The safety profile of sunitinib in children, including the impact of sunitinib exposure on safety endpoints, was assessed using population pharmacokinetic (PK) and pharmacokinetic–pharmacodynamic (PK–PD) models. METHODS: Data were from two clinical studies in 59 children with solid tumors (...
Gorde:
| Argitaratua izan da: | Cancer Chemother Pharmacol |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer Berlin Heidelberg
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7417410/ https://ncbi.nlm.nih.gov/pubmed/32623479 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00280-020-04106-z |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|